Cyclosporin in the treatment of adults with refractory coeliac disease - An open pilot study

Alimentary Pharmacology and Therapeutics

Volumn 14, Issue 6, 2000, Pages 767-774

  Wahab, ^a   Crusius, ^d   Meijer, ^c   Uil, ^b   Mulder, ^c  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b GELDERSE VALLEI HOSPITAL   (Netherlands)

^c RIJNSTATE HOSPITAL   (Netherlands)

^d VU UNIVERSITY AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; HLA DQ ANTIGEN;

ABDOMINAL CRAMP; ADULT; AGED; ARTICLE; CELIAC DISEASE; CLINICAL ARTICLE; DIARRHEA; DRUG BLOOD LEVEL; FEMALE; GASTROINTESTINAL INFECTION; GINGIVA HYPERPLASIA; HEADACHE; HLA TYPING; HUMAN; HUMAN TISSUE; HYPERTENSION; HYPERTRICHOSIS; INTESTINE BIOPSY; INTESTINE VILLUS; LIVER DYSFUNCTION; LYMPHOMA; MALE; NAUSEA; NEPHROTOXICITY; PARESTHESIA; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; SKIN INFECTION; TREMOR; URINARY TRACT INFECTION; VOMITING;

ADULT; AGED; CELIAC DISEASE; CYCLOSPORINE; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INTESTINAL MUCOSA; INTESTINE, SMALL; MALE; MIDDLE AGED; PILOT PROJECTS; RECURRENCE; TREATMENT OUTCOME;

EID: 0034040403     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.2000.00718.x     Document Type: Article

References (33)

1. 1 McNeish AS, Harms JK, Rey J, et al. The diagnosis of coeliac disease. A commentary on the current practice of members of the European Society for Paediatric Gastroenterology and Nutrition (ESPGAN). Arch Dis Child 1979; 54: 629-37.
2. 2 Walker-Smith JA, Guandalini S, Schmitz J, Shmerling DH, Visakorpi JK. Revised criteria for diagnosis of coeliac disease. Report of working group of European Society of Paediatric Gastroenterology and Nutrition. Arch Dis Child 1990; 65: 909-11.
3. 3 Grefte JM, Bouman JG, Grond J, Jansen W, Kleibeuker JH. Slow and incomplete histological and functional recovery in adult gluten sensitive enteropathy. J Clin Pathol 1988; 41: 886-91.
4. 4 Trier JS, Falchuk ZM, Carey MC, Schreiber DS. Celiac sprue and refractory sprue. Gastroenterology 1978; 75: 307-16.
5. 5 Baker AL, Rosenberg IH. Refractory sprue: recovery after removal of non gluten dietary proteins. Ann Intern Med 1978; 89: 505-8.
6. 6 O'Mahony S, Howdle PD, Losowsky MS. Review article: management of patients with non-responsive coeliac disease. Aliment Pharmacol Ther 1996; 10: 671-80.
7. 7 Cellier C, Patey N, Mauvieux L, et al. Abnormal intestinal intraepithelial lymphocytes in refractory sprue. Gastroenterology 1998; 114: 471-81.
8. 8 Carbonnel F, Grollet-Bioul L, Brouet JC, et al. Are complicated forms of celiac disease cryptic T-cell lymphomas? Blood 1998; 92: 3879-86.
9. 9 Brousse N, Verkarre V, Cellier C, et al. Is complicated celiac disease or refractory sprue an intestinal intra-epithelial cryptic T-cell lymphoma? Blood 1999; 93: 3154-5.
10. 10 Harris OD, Cooke WT, Thompson H, Waterhouse JAH. Malignancy in adult coeliac disease and idiopathic steatorrhoea. Am J Med 1967; 42: 899-912.
11. 11 Brandt L, Hagander B, Norden A, Stenstam M. Lymphoma of the small intestine in adult coeliac disease. Acta Med Scand 1978; 204: 467-70.
12. 12 Holmes GKT, Prior P, Lane MR, Pope D, Allan RN. Malignancy in coeliac disease - effect of a gluten free diet. Gut 1989; 30: 333-8.
13. 13 Editorial. Bone disease and gluten sensitivity: time to act, to treat and to prevent. Am J Gastroenterol 1994; 89: 2105-7.
14. 14 McFarlane XA, Bhalla AK, Reeves DE, Morgan LM, Robertson DAF. Osteoporosis in treated adult coeliac disease. Gut 1995; 36: 710-4.
15. 15 Corazza GR, Di Sario A, Cecchetti L, et al. Bone mass and metabolism in patients with celiac disease. Gastroenterology 1995; 109: 122-8.
16. 16 Collin P, Reunala T, Pukkala E, Laippala P, Keyrilainen O. Pasternack A. Coeliac disease-associated disorders and survival. Gut 1994; 35: 1215-8.
17. 17 Bernstein EF, Whitington PF. Successful treatment of atypical sprue in an infant with cyclosporin. Gastroenterology 1988; 95: 199-204.
18. 18 Longstreth GF. Successful treatment of refractory sprue with cyclosporin. Ann Int Med 1993; 119: 1014-6.
19. 19 Eijsbouts AMM, Witteman BJM, de Sevaux RGL, et al. Undefined malabsorption syndrome with villous atrophy successfully reversed by treatment with cyclosporin. Eur J Gastroenterol Hepatol 1995; 7: 803-6.
20. 20 Duerksen DR, Ma MM, Jewell LD. Failure of immunosuppressive therapy to prevent relapse of celiac sprue. J Clin Gastroenterol 1995; 21: 255-7.
21. 21 Gheorghe L, Popescu I, Gheorghe C, Aposteanu G, Popescu C, Oproiu A. Fatal intestinal hemorrhage complicating ileal lymphoma after cyclosporin for unresponsive celiac disease. Hepatogastroenterology 1997; 44: 1342-5.
22. 22 Faulds D, Goa KL, Benfield P. Cyclosporin. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in immunoregulatory disorders. Drugs 1993; 45: 953-1040.
23. 23 Lim KK, Su WP, Schroeter AL, Sabers CJ, Abraham RT, Pittelkow MR. Cyclosporin in the treatment of dermatological disease: an update. Mayo Clin Proc 1996; 71: 1182-91.
24. 24 Zachariae H, Steen-Olsen T. Efficacy of cyclosporin A (CyA) in psoriasis: an overview of dose/response, indications, contraindications and side effects. Clin Nephrol 1995; 43: 154-8.
25. 25 Przepiorka D, Weisdorf D, Martin P, et al. 1994 Consensus Conference on acute GVHD Grading. Bone Marrow Transplant 1995; 15: 825-8.
26. 26 Nilsen EM, Lundin KE, Krajci P, Scott H, Sollid LM, Brandtzaeg P. Gluten specific, HLA-DQ restricted T cells from coeliac mucosa produce cytokines with Th1 or Th0 profile dominated by interferon gamma. Gut 1995; 37: 766-76.
27. 27 Marsh MN. Gluten, major histocompatibility complex and the small intestine: a molecular and immunobiologic approach to the spectrum of gluten-sensitivity ('celiac sprue'). Gastroenterology 1992; 102: 330-54.
28. 28 Marsh MN, Crowe PT. Morphology of the mucosal lesion in gluten sensitivity. Baillieres Clin Gastroenterol 1995; 9: 273-93.
29. 29 Rostami K, Kerckhaert J, Blomberg BME, Meijer JWR, Mulder CJJ. Sensitivity of antiendomysium and antigliadin antibodies in untreated celiacs: disappointing in clinical practice. Am J Gastroenterol 1999; 94: 888-94.
30. 30 Uil JJ, van Elburg RM, Van Overbeek FM, Meijer JWR, Mulder CJJ. Heymans HSA. Follow up of treated coeliac patients: sugar absorption test and intestinal biopsies compared. Eur J Gastroenterol Hepatol 1996; 8: 219-23.
31. 31 Van Elburg RM, Uil JJ, Kokke FTM, et al. Repeatability of the sugar absorption test, using lactulose and mannitol, for measuring intestinal permeability for sugars. J Pediatr Gastroenterol Nutr 1995; 20: 184-8.
32. 32 Sollid LM, Marcussen G, Ek J, Gjerde H, Vartdal F, Thorsby E. Evidence for a primary association of celiac disease to a particular HLA-DQ α/β heterodimer. J Exp Med 1989; 169: 345-50.
33. 33 Orita M, Iwahana H, Kanazawa H, Hayashi K, Sekiya T. Detection of polymorphisms of human DNA by gel electrophoresis as single strand conformation polymorphisms. Proc Natl Acad Sci 1989; 86: 2766-70.